Literature DB >> 16407840

A functional analysis of PCNA-binding peptides derived from protein sequence, interaction screening and rational design.

E Warbrick1.   

Abstract

Proliferating cell nuclear antigen (PCNA) has no intrinsic enzymatic function, but functions as a sliding platform to mediate protein interactions with the DNA strand. Many proteins interact with PCNA through a small conserved motif with consensus QxxLxxFF. This work uses Schizosaccharomyces pombe and human cells to analyse the function of PCNA-binding peptides. Interacting peptides were identified using two-hybrid screening; one (pep102) binds directly to a physiologically relevant site on PCNA. The EGFP-pep102 overexpression phenotype is consistent with competitive blocking of PCNA-protein interactions. Various PCNA-binding peptides were all shown to inhibit PCNA function by competitive binding in both human and S. pombe cells as EGFP fusion proteins. The action of a p21(WAF1/Cip1)-derived peptide was complicated by the presence of additional functional domains and possible post-translational modification. The activity of pep102 was hampered by low expression in both model systems. The peptide derived from rational design (con1) was stable, highly active in inhibiting PCNA function both S. pombe and human cells and showed a high affinity for PCNA both in vitro and in vivo. These results validate the use of functional screening in yeast to identify peptide aptamers that are functional in mammalian cells; such aptamers provide excellent leads for small molecule antiproliferative therapies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16407840      PMCID: PMC2699888          DOI: 10.1038/sj.onc.1209320

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  38 in total

1.  A novel PCNA-binding motif identified by the panning of a random peptide display library.

Authors:  H Xu; P Zhang; L Liu; M Y Lee
Journal:  Biochemistry       Date:  2001-04-10       Impact factor: 3.162

Review 2.  Peptide inhibitors expressed in vivo.

Authors:  A Kamb; G Caponigro
Journal:  Curr Opin Chem Biol       Date:  2001-02       Impact factor: 8.822

3.  A CAF-1-PCNA-mediated chromatin assembly pathway triggered by sensing DNA damage.

Authors:  J G Moggs; P Grandi; J P Quivy; Z O Jónsson; U Hübscher; P B Becker; G Almouzni
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

Review 4.  PCNA binding proteins.

Authors:  T Tsurimoto
Journal:  Front Biosci       Date:  1999-12-01

Review 5.  The puzzle of PCNA's many partners.

Authors:  E Warbrick
Journal:  Bioessays       Date:  2000-11       Impact factor: 4.345

6.  Dominant effector genetics in mammalian cells.

Authors:  X Xu; C Leo; Y Jang; E Chan; D Padilla; B C Huang; T Lin; T Gururaja; Y Hitoshi; J B Lorens; D C Anderson; B Sikic; Y Luo; D G Payan; G P Nolan
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

7.  A quantitative study of the in vitro binding of the C-terminal domain of p21 to PCNA: affinity, stoichiometry, and thermodynamics.

Authors:  D I Zheleva; N Z Zhelev; P M Fischer; S V Duff; E Warbrick; D G Blake; D P Lane
Journal:  Biochemistry       Date:  2000-06-27       Impact factor: 3.162

8.  Essential interaction between the fission yeast DNA polymerase delta subunit Cdc27 and Pcn1 (PCNA) mediated through a C-terminal p21(Cip1)-like PCNA binding motif.

Authors:  N Reynolds; E Warbrick; P A Fantes; S A MacNeill
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

9.  The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA.

Authors:  S Waga; G J Hannon; D Beach; B Stillman
Journal:  Nature       Date:  1994-06-16       Impact factor: 49.962

10.  Isolation and analysis of the fission yeast gene encoding polymerase delta accessory protein PCNA.

Authors:  N H Waseem; K Labib; P Nurse; D P Lane
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

View more
  20 in total

Review 1.  Postreplicative mismatch repair.

Authors:  Josef Jiricny
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-04-01       Impact factor: 10.005

2.  Characterization of the proliferating cell nuclear antigen of Leishmania donovani clinical isolates and its association with antimony resistance.

Authors:  Rati Tandon; Sharat Chandra; Rajendra Kumar Baharia; Sanchita Das; Pragya Misra; Awanish Kumar; Mohammad Imran Siddiqi; Shyam Sundar; Anuradha Dube
Journal:  Antimicrob Agents Chemother       Date:  2014-03-10       Impact factor: 5.191

3.  A structural hinge in eukaryotic MutY homologues mediates catalytic activity and Rad9-Rad1-Hus1 checkpoint complex interactions.

Authors:  Paz J Luncsford; Dau-Yin Chang; Guoli Shi; Jade Bernstein; Amrita Madabushi; Dimeka N Patterson; A-Lien Lu; Eric A Toth
Journal:  J Mol Biol       Date:  2010-09-15       Impact factor: 5.469

4.  bioPROTACs as versatile modulators of intracellular therapeutic targets including proliferating cell nuclear antigen (PCNA).

Authors:  Shuhui Lim; Regina Khoo; Khong Ming Peh; Jinkai Teo; Shih Chieh Chang; Simon Ng; Greg L Beilhartz; Roman A Melnyk; Charles W Johannes; Christopher J Brown; David P Lane; Brian Henry; Anthony W Partridge
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-02       Impact factor: 11.205

5.  Developing peptide-based multivalent antagonists of proliferating cell nuclear antigen and a fluorescence-based PCNA binding assay.

Authors:  William P Bozza; Kun Yang; Jialiang Wang; Zhihao Zhuang
Journal:  Anal Biochem       Date:  2012-04-20       Impact factor: 3.365

6.  C-terminal flap endonuclease (rad27) mutations: lethal interactions with a DNA ligase I mutation (cdc9-p) and suppression by proliferating cell nuclear antigen (POL30) in Saccharomyces cerevisiae.

Authors:  Kenneth K Karanja; Dennis M Livingston
Journal:  Genetics       Date:  2009-07-13       Impact factor: 4.562

7.  A Peptide mimicking a region in proliferating cell nuclear antigen specific to key protein interactions is cytotoxic to breast cancer.

Authors:  Shanna J Smith; Long Gu; Elizabeth A Phipps; Lacey E Dobrolecki; Karla S Mabrey; Pattie Gulley; Kelsey L Dillehay; Zhongyun Dong; Gregg B Fields; Yun-Ru Chen; David Ann; Robert J Hickey; Linda H Malkas
Journal:  Mol Pharmacol       Date:  2014-12-05       Impact factor: 4.436

8.  Streamlined, automated protocols for the production of milligram quantities of untagged recombinant human cyclophilin-A (hCypA) and untagged human proliferating cell nuclear antigen (hPCNA) using AKTAxpress.

Authors:  Cornelia Ludwig; Martin A Wear; Malcolm D Walkinshaw
Journal:  Protein Expr Purif       Date:  2009-12-06       Impact factor: 1.650

9.  Proliferating cell nuclear antigen acts as a cytoplasmic platform controlling human neutrophil survival.

Authors:  Véronique Witko-Sarsat; Julie Mocek; Dikra Bouayad; Nicola Tamassia; Jean-Antoine Ribeil; Céline Candalh; Noélie Davezac; Nathalie Reuter; Luc Mouthon; Olivier Hermine; Magali Pederzoli-Ribeil; Marco A Cassatella
Journal:  J Exp Med       Date:  2010-10-25       Impact factor: 14.307

10.  Identification of a novel, widespread, and functionally important PCNA-binding motif.

Authors:  Karin M Gilljam; Emadoldin Feyzi; Per A Aas; Mirta M L Sousa; Rebekka Müller; Cathrine B Vågbø; Tara C Catterall; Nina B Liabakk; Geir Slupphaug; Finn Drabløs; Hans E Krokan; Marit Otterlei
Journal:  J Cell Biol       Date:  2009-09-07       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.